RE:RE:The time arrived 15 years ago, but the "rewards" just now? I'm not sure Toray would forgo 125 plus billion in cumulative global revenue, treatment exposure and patent establishment so some execs at a pee on Canadian biotech can enrich themselves through 15 years of delay to sell for $8.00 a share, but Ok it makes perfect business sense. I'm assuming that was a response to Alex Jones....